top of page
Spearpoint Analytics

Have you been affected of prostate cancer?

Our more accurate analysis provides you a more confident decision

DID YOU KNOW THAT

Up to 20% of all treatments are incorrect - our method gives doctors a reliable basis for decision-making.

IS YOUR PROSTATE CANCER AGGRESSIVE OR NOT?

Uncertain diagnoses can lead to unnecessary treatment

SpearPoint Analytics

For prostate cancer, it’s crucial to understand how aggressive the disease is.
 

If the cancer is aggressive, treatment should proceed quickly — usually surgery or radiation.

If the cancer is not aggressive, you may be able to wait. This helps avoid serious side effects such as impotence and incontinence.
 

Today, aggressiveness is assessed using an older method that often yields inconsistent results.

Because of this uncertainty, urologists sometimes take a safety-first approach - for example,  “Let’s operate, just in case”. This can now be avoided.

Our accurate analysis gives your urologist a more reliable basis for decision-making.

We offer a second opinion based on PCAI (Prostate Cancer Aggressiveness Index). Your tissue samples are compared with a unique database of approximately 20.000 patients with over 20 years of following up.

PCAI outperforms human experts in determining the aggressiveness ofprostate cancer is. It can reduce unnecessary surgery while highlighting cases that requires rapid, radical treatment that might otherwise be missed.

With PCAI you get:

 

✔ Confirmation that the current treatment plan is appropriate – creating confidence.


✔ Advice to wait when appropriate – avoiding side effects  such as impotence and incontinence.


✔ Early warning of aggressive cancer – so treatment can begin in time.

SpearPoint Analytics

How it works

To create this security, we offer you a Second Opinion

1.

Book a free meeting

Click "Book a digital meeting" below, to have all your questions answered.

2.

Order a Second Opinion

If you decide it's right for you after the meeting, you can easily place the order.

3.

We contact your urologist (with your approval)

We inform your urologist about the process and collaborate for the best possible care.

4.

We collect your biopsy images and patient data

We gather your digitized tissue samples (biopsies) and other relevant information.

5.

Cancer areas are identified

Our AI-based cancer detector analyzes the tissue samples and identifies suspicious areas.

6.

PCAI Analysis and medical assessment

PCAI analyses your data. Our urologist reviews the results, documents them in your medical record, and provides feedback in a digital meeting.

7.

You will receive a written report

The report includes a section for you (patient) and a section for your urologist,, both clearly presented.

8.

Optional joint appointment

A meeting between your doctor, our urologist, and you to discuss the results and agree on the best decision.

IT IS WISE TO CONSULT

You are welcome to contact us to discuss a second opinion.

bottom of page